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Confusion and controversy loom
large whenever autistic spectrum
disorders are discussed. A major
review commissioned by the
British government should sort
the facts from the legends,
hopes Michael Gross.
The raging debate on whether or not
the combined measles, mumps and
rubella (MMR) vaccine can trigger
the onset of autistic spectrum
disorders (latest research suggests it
doesn’t) has demonstrated one thing
very clearly: that there is a lot of
uncertainty and misinformation
about autism, a condition that affects
0.1% of the population. Parents of
autistic children know how difficult
it is to filter any meaningful
information from a stream of dubious
reports on miracle cures, horrifying
increases in case numbers, newly
identified causes, and new theories.
Short of a cure, weeding out the
information jungle would be a major
step to make life easier for
everybody involved. Similarly, a
future-oriented research policy
capable of tackling the disease
would need to be based on a clear
understanding of what can presently
count as established knowledge, and
what is mythology. 
In response to this problem, the
British government has recently
commissioned the Medical Research
Council (MRC) to provide a report
on the present scientific knowledge
about the epidemiology and causes of
autism. The MRC has set up three
expert panels and a ‘lay group’
consisting of people involved with
autism in non-academic ways. 
There is first the case definition
and epidemiology group. This group
will have to address questions such as
whether the apparent increase in case
numbers over the past decade is an
artefact of shifting definitions, or
whether there is a real ‘epidemic’. If
the increase is real, then there must
be biological causes for it, which may
be found in the remit of the
physiology and infections group
which has possibly the trickiest task,
including the MMR question along
with other possible environmental
influences on the condition. While
there is a clear genetic component to
autism (around a dozen genes are
thought to be involved), the disorder
is also linked to bowel malfunctions,
which led to theories that blame the
symptoms on food ingredients such
as milk proteins or gluten. Finally,
there is a group dealing with
psychology and behaviour. As the
psychological ‘causes’ of autism
postulated in the 1950s have by now
been ruled out completely, and
educational provision is excluded
from the remit of the review, this last
part of the review is likely to stir less
controversy than the others. 
Of the six ‘lay group’ members,
two are associated with each of the
review groups. The panels’
membership sparked some
controversy. Andrew Wakefield, the
researcher who claimed that the
MMR vaccine triggered autism, was
said to be concerned about the fact
that four members, including two
academics and one lay group
member serving on the physiology
board, had been involved in the
court case brought against
manufacturers of the MMR vaccine
by parents. The view that this
constitutes a conflict of interest,
however, did not prevail. 
The report should become
publicly available by the end of this
year. MRC research boards will
consider the results with a view to
convert its suggestions into actual
research that will put an end to
decades of confusion. 
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